Source: Eur Respir J 2008; 32: 362-371
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Ward J. E., Harris T., Bamford T., Mast A., Pain M. C. F., Robertson C., Smallwood D., Tran T., Wilson J., Stewart A. G.. Proliferation is not increased in airway myofibroblasts isolated from asthmatics. Eur Respir J 2008; 32: 362-371

Member's Comments

No comment yet.

Related content which might interest you: Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison Source: Eur Respir J 2007; 30: 653-661 Year: 2007 Fluticasone and salmeterol downregulate in vitro, fibroblast proliferation and ICAM-1 or H-CAM expression Source: Eur Respir J 2001; 18: 139-145 Year: 2001 A comparison of beta2-adrenoceptor desensitisation induced by olodaterol and formoterol in human lung mast cells and airway smooth muscle cells Source: Annual Congress 2013 –New drugs in respiratory medicine Year: 2013 Inhaled budesonide induces corticosteroid-dependent gene expression in asthmatics: Validation in primary epithelial and airways smooth muscle cells Source: Annual Congress 2011 - Models of disease and drug actions Year: 2011 Formoterol reduces asthmatic airway smooth muscle cell proliferation through p27 (Kip) which is supported by steroids Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD Year: 2012 The long-acting β2-agonist formoterol re-establishes the anti-proliferative effect of glucocorticoids in asthmatic airway smooth muscle cells (ASMC) Source: Annual Congress 2011 - Understanding disease and drug mechanisms Year: 2011 Effects of fluticasone and salmeterol on cytokine-induced airway smooth muscle IP10 release Source: Eur Respir J 2005; 26: Suppl. 49, 712s Year: 2005 Rolipram and salmeterol block β1/β2-integrin-mediated adhesion of eosinophils to cultured airway smooth muscle cells from non-asthmatic and asthmatic donors Source: Eur Respir J 2003; 22: Suppl. 45, 454s Year: 2003 Treating asthma means treating airway smooth muscle cells Source: Eur Respir J 2008; 32: 265-274 Year: 2008 Beta2-agonists but not glucocorticoids inhibit proliferation of asthmatic airway smooth muscle cells Source: Eur Respir J 2004; 24: Suppl. 48, 251s Year: 2004 Decreased hyaluronan in airway smooth muscle cells of asthma and COPD patients Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of COPD Year: 2009 Inhibition of IL-8 and RANTES release from cultured human airway smooth muscle cells by fluticasone and budesonide Source: Eur Respir J 2002; 20: Suppl. 38, 384s Year: 2002 Fluticasone induces apoptosis in peripheral T-lymphocytes: a comparison between asthmatic and normal subjects Source: Eur Respir J 2002; 19: 257-266 Year: 2002 Allergen-induced airway decorin production is inhibited by budesonide and formoterol in a mouse model of asthma Source: Eur Respir J 2004; 24: Suppl. 48, 690s Year: 2004 Contractility of bronchial smooth muscle and changes during disease Source: Annual Congress 2005 - Role of the bronchial smooth muscle in regulating airway disease Year: 2005 Inhaled corticosteroids and growth of airway function in asthmatic children Source: Eur Respir J 2004; 23: 861-868 Year: 2004 CCL2 release by airway smooth muscle is increased in asthma and promotes fibrocyte migration Source: International Congress 2014 – Cell biology 2014 Year: 2014 Long-term effects of bronchial thermoplasty on airway smooth muscle and collagen deposition in severe asthma Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives Year: 2016 Decreased hyaluronan in airway smooth muscle cells from patients with asthma and COPD Source: Eur Respir J 2009; 34: 616 Year: 2009 IL-13 induces glucocorticoid-insensitive hyperreactivity of human small airways Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015